Immunophenotyping at the Time of Diagnosis Distinguishes Two Groups of Nasopharyngeal Carcinoma Patients: Implications for Adoptive Immunotherapy

Background: Adoptive immunotherapy with EBV-specific CTLs (EBV-CTL) has been used to treat EBV-associated nasopharyngeal carcinoma (NPC) but only a fraction of the patients shows noticeable clinical response. Patients and Methods: Sixty-seven newly diagnosed NPC patients from 2005 to 2007 and 21 hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiang, Chen, Qiu-yan, Mo, Haoyuan, Zhang, Yi-lan, Huang, Zhou-feng, Zeng, Yi-xin
Formato: Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2011
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101529/
https://www.ncbi.nlm.nih.gov/pubmed/21614153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101529/
https://www.ncbi.nlm.nih.gov/pubmed/21614153

Ejemplares similares